[1st clinical experience with a new oral hypoglycemic agent: tolazamide, 1-(hexahydro-1-azepinyl)-3-p-tolysulfonylurea].
D006801:Humans; D007004:Hypoglycemic Agents; D014042:Tolazamide
D007004:Hypoglycemic Agents; D014042:Tolazamide
ANTIDIABETICS